UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Commentary on the MID3 Good Practices Paper

Manolis, E; Brogren, J; Cole, S; Pittaway-Hay, J; Nordmark, A; Karlsson, KE; Lentz, F; ... EMA MSWG Group; + view all (2017) Commentary on the MID3 Good Practices Paper. CPT: Pharmacometrics & Systems Pharmacology , 6 (7) pp. 416-417. 10.1002/psp4.12223. Green open access

[thumbnail of Commentary on the MID3 Good Practices Paper.pdf]
Preview
Text
Commentary on the MID3 Good Practices Paper.pdf - Published Version

Download (73kB) | Preview

Abstract

During the last 10 years the European medicines Agency (EMA) organised a number of workshops on modelling and simulation, working towards greater integration of modelling and simulation (M&S) in the development and regulatory assessment of medicines. In the 2011 EMA - European Federation of Pharmaceutical Industries and Associations (EFPIA) workshop on Modelling and Simulation European regulators agreed to the necessity to build to expertise be able to review M&S data provided by companies in their dossier. This lead to the establishment of the EMA modelling and simulation working group (MSWG). Also there was agreement reached on the need for harmonisation on good M&S practices and for continuing dialogue across all parties. The MSWG acknowledges the initiative of the EFPIA Model-Informed Drug Discovery and Development (MID3) group in promoting greater consistency in practice, application and documentation of M&S and considers the paper is an important contribution towards achieving this objective.

Type: Article
Title: Commentary on the MID3 Good Practices Paper
Location: United States
Open access status: An open access version is available from UCL Discovery
DOI: 10.1002/psp4.12223
Publisher version: http://dx.doi.org/10.1002/psp4.12223
Language: English
Additional information: Copyright © 2017 The Authors CPT: Pharmacometrics & Systems Pharmacology published by Wiley Periodicals, Inc. on behalf of American Society for Clinical Pharmacology and Therapeutics. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL GOS Institute of Child Health
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL GOS Institute of Child Health > Infection, Immunity and Inflammation Dept
URI: https://discovery.ucl.ac.uk/id/eprint/1560514
Downloads since deposit
126Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item